Ulrike A. Nuber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ulrike A. Nuber has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Alina Filatova
Stem Cell and Developmental Biology, Technical University of Darmstadt, 64287 Darmstadt, Germany
3 shared publications Nils Offen
Stem Cell and Developmental Biology, Technical University of Darmstadt, Darmstadt, Germany
3 shared publicationsAlina Filatova
Stem Cell and Development Biology, Department of Biology Technical University of Darmstadt Germany
2 shared publicationsGaëlle Prost
Lund Strategic Center for Stem Cell Biology, Lund University, Lund, Sweden
2 shared publicationsAlaa Alsaafin
Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada; Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada
1 shared publicationAlexandra Chittka
Cell Biology and Epigenetics, Department of Biology, Technical University of Darmstadt, Darmstadt, Germany
1 shared publication
Latest Publications
- Open Access
Tube-in-tube oxygen saturator enabling precise and dynamic control of liquid-phase oxygen concentrations for human cell culture applications
This study demonstrates the feasibility of using a Teflon-AF-based tube-in-tube saturator for fast and precise adjustment of oxygen concentrations in liquids, extending its relevance to human cell culture applications beyond organ-on-chip systems. The system achieves high, near-saturation oxygen concentrations of the liquid phase, with performance influenced by various parameters such as temperature, volume flow rate, and tube length. We demonstrate that the tube-in-tube saturator exhibits high sensitivity to variations in these parameters at low oxygen concentrations, whereas this sensitivity diminishes as saturation is approached. To elucidate the underlying mass transfer processes, kinetic experiments were combined with computational fluid dynamics simulations. The simulation results are in good agreement with the experimental data, and the developed model enables a reliable prediction of oxygen concentrations in the liquid phase under varying operating conditions. Owing to its design, performance, versatility, and portability, this system introduces a new approach for the precise and rapid control of oxygen concentrations in liquids for microscale and macroscale human cell culture applications, offering seamless integration with natural vascular or artificial perfusion networks.
Open AccessTube-in-tube oxygen saturator enabling precise and dynamic control of liquid-phase oxygen concentrations for human cell culture applications
This study demonstrates the feasibility of using a Teflon-AF-based tube-in-tube saturator for fast and precise adjustment of oxygen concentrations in liquids, extending its relevance to human cell culture applications beyond organ-on-chip systems. The system achieves high, near-saturation oxygen concentrations of the liquid phase, with performance influenced by various parameters such as temperature, volume flow rate, and tube length. We demonstrate that the tube-in-tube saturator exhibits high sensitivity to variations in these parameters at low oxygen concentrations, whereas this sensitivity diminishes as saturation is approached. To elucidate the underlying mass transfer processes, kinetic experiments were combined with computational fluid dynamics simulations. The simulation results are in good agreement with the experimental data, and the developed model enables a reliable prediction of oxygen concentrations in the liquid phase under varying operating conditions. Owing to its design, performance, versatility, and portability, this system introduces a new approach for the precise and rapid control of oxygen concentrations in liquids for microscale and macroscale human cell culture applications, offering seamless integration with natural vascular or artificial perfusion networks.
- Open Access
Self‐Organized Vascularized Human Liver Spheroids: Serum‐Free Culture Conditions and Use as Tissue Building Blocks
Engineering vascularized human liver tissue for in vitro and in vivo applications remains a major challenge. Here, we describe a scalable approach to generate human liver spheroids with self‐organized, lumen‐containing vascular networks and demonstrate their use as building blocks for fabricating vascularized single and multilayer tissue constructs. Spheroids were formed from HepaRG liver cells, human umbilical vein endothelial cells, and adipose tissue‐derived mesenchymal stem cells. Including the latter in specific ratios prevented a spatial segregation of hepatic and endothelial compartments, enabling endothelial network formation. We present two media for culturing these spheroids: a serum‐reduced medium and a defined serum‐free medium containing Gibco KnockOut Serum Replacement. These media supported the long‐term maintenance of hepatocytes in a metabolically active, relatively mature state, as well as the persistence of endothelial networks. Spheroid‐derived endothelial cells established anastomoses with external endothelial channels in microfluidic devices, and upon grafting into mouse liver tissue extended into the host parenchyma. Moreover, endothelial sprouts emerging from the spheroids formed inter‐spheroid connections within permissive hydrogels, a process that depended on the inter‐spheroid distance. Finally, we demonstrate the fabrication of planar tissue layers with vascularly interconnected spheroids and the creation of a macroscale tissue construct from several such layers.
Open AccessSelf‐Organized Vascularized Human Liver Spheroids: Serum‐Free Culture Conditions and Use as Tissue Building Blocks
Engineering vascularized human liver tissue for in vitro and in vivo applications remains a major challenge. Here, we describe a scalable approach to generate human liver spheroids with self‐organized, lumen‐containing vascular networks and demonstrate their use as building blocks for fabricating vascularized single and multilayer tissue constructs. Spheroids were formed from HepaRG liver cells, human umbilical vein endothelial cells, and adipose tissue‐derived mesenchymal stem cells. Including the latter in specific ratios prevented a spatial segregation of hepatic and endothelial compartments, enabling endothelial network formation. We present two media for culturing these spheroids: a serum‐reduced medium and a defined serum‐free medium containing Gibco KnockOut Serum Replacement. These media supported the long‐term maintenance of hepatocytes in a metabolically active, relatively mature state, as well as the persistence of endothelial networks. Spheroid‐derived endothelial cells established anastomoses with external endothelial channels in microfluidic devices, and upon grafting into mouse liver tissue extended into the host parenchyma. Moreover, endothelial sprouts emerging from the spheroids formed inter‐spheroid connections within permissive hydrogels, a process that depended on the inter‐spheroid distance. Finally, we demonstrate the fabrication of planar tissue layers with vascularly interconnected spheroids and the creation of a macroscale tissue construct from several such layers.
- Open Access
- 11 July 2026
- Published by Elsevier in Biomaterials
- Vol. 336
High-resolution fabrication of porous microtubular scaffolds for vascular tissue engineering using two-photon stereolithography
- 11 July 2026
- Published by Elsevier in Biomaterials
- Vol. 336
Open AccessHigh-resolution fabrication of porous microtubular scaffolds for vascular tissue engineering using two-photon stereolithography
- Open Access
- 1 June 2026
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 236, 115907
Guiding the spatial organization of engineered heart tissues
- 1 June 2026
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 236, 115907
Open AccessGuiding the spatial organization of engineered heart tissues
- Open Access
- 28 June 2024
- Published by Walter de Gruyter GmbH in at - Automatisierungstechnik
- Vol. 72 (7) , 638-644
The fabrication-assembly challenge in tissue engineering
The generation of human tissue through tissue engineering has been pursued for decades and is still associated with major challenges. The comparison between natural tissue formation and engineering concepts helps to understand the fabrication-assembly challenge of tissue components and provides approaches to solutions for this multidisciplinary field.
- 28 June 2024
- Published by Walter de Gruyter GmbH in at - Automatisierungstechnik
- Vol. 72 (7) , 638-644
Open AccessThe fabrication-assembly challenge in tissue engineering
The generation of human tissue through tissue engineering has been pursued for decades and is still associated with major challenges. The comparison between natural tissue formation and engineering concepts helps to understand the fabrication-assembly challenge of tissue components and provides approaches to solutions for this multidisciplinary field.
- Open Access
- 28 June 2024
- Published by Walter de Gruyter GmbH in at - Automatisierungstechnik
- Vol. 72 (7) , 579-584
Biological engineering – an engineering discipline crucial to the future of our civilization
Biological engineering is a new engineering discipline that is paving the way for new products and processes based on findings from biology. These allow for environmentally friendly production, use and disposal while at the same time creating high added value. Like any engineering discipline, biological engineering requires a sound university education, which is already being provided at many North American universities. The aim of the article is to motivate policymakers to take note of this development and to establish comparable departments and degree programs in the EU.
- 28 June 2024
- Published by Walter de Gruyter GmbH in at - Automatisierungstechnik
- Vol. 72 (7) , 579-584
Open AccessBiological engineering – an engineering discipline crucial to the future of our civilization
Biological engineering is a new engineering discipline that is paving the way for new products and processes based on findings from biology. These allow for environmentally friendly production, use and disposal while at the same time creating high added value. Like any engineering discipline, biological engineering requires a sound university education, which is already being provided at many North American universities. The aim of the article is to motivate policymakers to take note of this development and to establish comparable departments and degree programs in the EU.
- Open Access
- 2 November 2023
- Published by Elsevier in Stem Cell Reports
- Vol. 18 (11) , 2240-2253
Enrichment of FGF8-expressing cells from neurally induced human pluripotent stem cell cultures
- 2 November 2023
- Published by Elsevier in Stem Cell Reports
- Vol. 18 (11) , 2240-2253
Open AccessEnrichment of FGF8-expressing cells from neurally induced human pluripotent stem cell cultures
- Open Access
- 4 October 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 5 (21) , 5859-5869
Surfactant-driven optimization of iron-based nanoparticle synthesis: a study on magnetic hyperthermia and endothelial cell uptake
This work examines the effect of changing the ratio of different surfactants in single-core iron-based nanoparticles with respect to their specific absorption rate in the context of magnetic hyperthermia and cellular uptake by human umbilical vein endothelial cells (HUVEC). Three types of magnetic nanoparticles were synthesized by separately adding oleic acid or oleylamine or a mixture of both (oleic acid/oleylamine) as surfactants. A carefully controlled thermal decomposition synthesis process led to monodispersed nanoparticles with a narrow size distribution. Spherical-shaped nanoparticles were mainly obtained for those synthesized with oleic acid, while the shape changed upon adding oleylamine. The combined use of oleic acid and oleylamine as surfactants in single-core iron-based nanoparticles resulted in a substantial saturation magnetization, reaching up to 140 A m2 kg−1 at room temperature. The interplay between these surfactants played a crucial role in achieving this high magnetic saturation. By modifying the surface of the magnetic nanoparticles using a mixture of two surfactants, the magnetic fluid hyperthermia heating rate was significantly improved compared to using a single surfactant type. This improvement can be attributed to the larger effective anisotropy achieved through the modification with both (oleic acid/oleylamine). The mixture of surfactants enhances the control of interparticle distance and influences the strength of dipolar interactions, ultimately leading to enhanced heating efficiency. Functionalization of the oleic acid-coated nanoparticles with trimethoxysilane results in the formation of a core–shell structure Fe@Fe3O4, showing exchange bias (EB) associated with the exchange anisotropy between the shell and the core. The biomedical relevance of our synthesized Fe@Fe3O4 nanoparticles was demonstrated by their efficient uptake by human umbilical vein endothelial cells (HUVECs) in a concentration-dependent manner. This remarkable cellular uptake highlights the potential of these nanoparticles in biomedical applications.
- 4 October 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 5 (21) , 5859-5869
Open AccessSurfactant-driven optimization of iron-based nanoparticle synthesis: a study on magnetic hyperthermia and endothelial cell uptake
This work examines the effect of changing the ratio of different surfactants in single-core iron-based nanoparticles with respect to their specific absorption rate in the context of magnetic hyperthermia and cellular uptake by human umbilical vein endothelial cells (HUVEC). Three types of magnetic nanoparticles were synthesized by separately adding oleic acid or oleylamine or a mixture of both (oleic acid/oleylamine) as surfactants. A carefully controlled thermal decomposition synthesis process led to monodispersed nanoparticles with a narrow size distribution. Spherical-shaped nanoparticles were mainly obtained for those synthesized with oleic acid, while the shape changed upon adding oleylamine. The combined use of oleic acid and oleylamine as surfactants in single-core iron-based nanoparticles resulted in a substantial saturation magnetization, reaching up to 140 A m2 kg−1 at room temperature. The interplay between these surfactants played a crucial role in achieving this high magnetic saturation. By modifying the surface of the magnetic nanoparticles using a mixture of two surfactants, the magnetic fluid hyperthermia heating rate was significantly improved compared to using a single surfactant type. This improvement can be attributed to the larger effective anisotropy achieved through the modification with both (oleic acid/oleylamine). The mixture of surfactants enhances the control of interparticle distance and influences the strength of dipolar interactions, ultimately leading to enhanced heating efficiency. Functionalization of the oleic acid-coated nanoparticles with trimethoxysilane results in the formation of a core–shell structure Fe@Fe3O4, showing exchange bias (EB) associated with the exchange anisotropy between the shell and the core. The biomedical relevance of our synthesized Fe@Fe3O4 nanoparticles was demonstrated by their efficient uptake by human umbilical vein endothelial cells (HUVECs) in a concentration-dependent manner. This remarkable cellular uptake highlights the potential of these nanoparticles in biomedical applications.
- Open Access
- 12 September 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 941493
MeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation
Rett syndrome is a human intellectual disability disorder that is associated with mutations in the X-linked MECP2 gene. The epigenetic reader MeCP2 binds to methylated cytosines on the DNA and regulates chromatin organization. We have shown previously that MECP2 Rett syndrome missense mutations are impaired in chromatin binding and heterochromatin reorganization. Here, we performed a proteomics analysis of post-translational modifications of MeCP2 isolated from adult mouse brain. We show that MeCP2 carries various post-translational modifications, among them phosphorylation on S80 and S421, which lead to minor changes in either heterochromatin binding kinetics or clustering. We found that MeCP2 is (di)methylated on several arginines and that this modification alters heterochromatin organization. Interestingly, we identified the Rett syndrome mutation site R106 as a dimethylation site. In addition, co-expression of protein arginine methyltransferases (PRMT)1 and PRMT6 lead to a decrease of heterochromatin clustering. Altogether, we identified and validated novel modifications of MeCP2 in the brain and show that these can modulate its ability to bind as well as reorganize heterochromatin, which may play a role in the pathology of Rett syndrome.
- 12 September 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 941493
Open AccessMeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation
Rett syndrome is a human intellectual disability disorder that is associated with mutations in the X-linked MECP2 gene. The epigenetic reader MeCP2 binds to methylated cytosines on the DNA and regulates chromatin organization. We have shown previously that MECP2 Rett syndrome missense mutations are impaired in chromatin binding and heterochromatin reorganization. Here, we performed a proteomics analysis of post-translational modifications of MeCP2 isolated from adult mouse brain. We show that MeCP2 carries various post-translational modifications, among them phosphorylation on S80 and S421, which lead to minor changes in either heterochromatin binding kinetics or clustering. We found that MeCP2 is (di)methylated on several arginines and that this modification alters heterochromatin organization. Interestingly, we identified the Rett syndrome mutation site R106 as a dimethylation site. In addition, co-expression of protein arginine methyltransferases (PRMT)1 and PRMT6 lead to a decrease of heterochromatin clustering. Altogether, we identified and validated novel modifications of MeCP2 in the brain and show that these can modulate its ability to bind as well as reorganize heterochromatin, which may play a role in the pathology of Rett syndrome.
- Open Access
- 4 July 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Mutations in SMARCB1 and in other Coffin–Siris syndrome genes lead to various brain midline defects
Mutations in genes encoding components of BAF (BRG1/BRM-associated factor) chromatin remodeling complexes cause neurodevelopmental disorders and tumors. The mechanisms leading to the development of these two disease entities alone or in combination remain unclear. We generated mice with a heterozygous nervous system-specific partial loss-of-function mutation in a BAF core component gene, Smarcb1. These Smarcb1 mutant mice show various brain midline abnormalities that are also found in individuals with Coffin–Siris syndrome (CSS) caused by SMARCB1, SMARCE1, and ARID1B mutations and in SMARCB1-related intellectual disability (ID) with choroid plexus hyperplasia (CPH). Analyses of the Smarcb1 mutant animals indicate that one prominent midline abnormality, corpus callosum agenesis, is due to midline glia aberrations. Our results establish a novel role of Smarcb1 in the development of the brain midline and have important clinical implications for BAF complex-related ID/neurodevelopmental disorders.
- 4 July 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Open AccessMutations in SMARCB1 and in other Coffin–Siris syndrome genes lead to various brain midline defects
Mutations in genes encoding components of BAF (BRG1/BRM-associated factor) chromatin remodeling complexes cause neurodevelopmental disorders and tumors. The mechanisms leading to the development of these two disease entities alone or in combination remain unclear. We generated mice with a heterozygous nervous system-specific partial loss-of-function mutation in a BAF core component gene, Smarcb1. These Smarcb1 mutant mice show various brain midline abnormalities that are also found in individuals with Coffin–Siris syndrome (CSS) caused by SMARCB1, SMARCE1, and ARID1B mutations and in SMARCB1-related intellectual disability (ID) with choroid plexus hyperplasia (CPH). Analyses of the Smarcb1 mutant animals indicate that one prominent midline abnormality, corpus callosum agenesis, is due to midline glia aberrations. Our results establish a novel role of Smarcb1 in the development of the brain midline and have important clinical implications for BAF complex-related ID/neurodevelopmental disorders.